WeHand-Bio

WeHand-Bio Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 3

WeHand-Bio General Information

Description

Provider of drug research and development services intended to focus on the treatment of diabetic diseases. The company creates drugs used mainly for the treatment of diabetes, tumors and influenza, enabling the clients to receive patented drugs which can be used both in tablet and injection form.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • Zhongguancun Science and Technology Park
  • Beijing Daxing bio-pharmaceutical industry base 30 Tianfu Street
  • Beijing, 102600
  • China
+86 010 0000 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

WeHand-Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Jan-2015 Completed Generating Revenue

WeHand-Bio Investors (3)

To view WeHand-Bio‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cowin Capital Venture Capital Minority 000 0000 000000 0
Lang Sheng Investment Venture Capital Minority 000 0000 000000 0
Northern Light Venture Capital Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial